Summary Aryl hydrocarbon hydroxylase (AHH) activity was measured in the breast tumours of 153 primary and 17 recurrent cancer patients, and in 18 patients with benign breast tumour. All operations were carried out in 1983-84. The cytosolic fraction was collected for steroid receptor determination, and microsomes were separated for AHH assay from the same tissue samples. The AHH distribution was wide and highly skewed in all groups. About 10% of the samples showed activities below detection limit. The medians and ranges for primary cancers were 34 (<5-2683), for recurrent cancers 40 (20-239) (Lynch et al., 1984; Thomas, 1984; Mettlin, 1984 
The cytochrome P450-dependent monooxygenases play a key role in the metabolism of a wide variety of xenobiotics, such as drugs, environmental pollutants, carcinogens and also steroids, including several chemotherapeutic agents used in cancer treatment. Cytochrome P450 is found in animals and in humans as multiple isoenzymes (Nebert & Conzalez, 1987) , the relative amounts and activities of which may largely govern the balance between bioactivation and detoxification of a particular compound (Pelkonen & Nebert, 1982) . Aryl hydrocarbon hydroxylase (AHH), a cytochrome P450 activity induced by polycyclic aromatic hydrocarbons (PAH), is considered the most important enzyme in the metabolic activation of several compounds, especially PAH, into ultimate carcinogenic forms (Pelkonen & Nebert, 1982) . The induction of AHH is genetically controlled by Ahreceptors (Nebert & Gonzalez, 1987) . In animal models, levels of AHH activity are linked to susceptibility to chemical carcinogen induced sarcomas, skin carcinomas, lung carcinomas, and lymphomas and leukaemias (Kouri et al., 1982) . Many efforts have been made to determine a relationship between AHH activity or inducibility and susceptibility to lung cancer or other forms of cancer also in human populations, but the results vary and are mostly contradictory (Kouri et al., 1982; Karki et al., 1987) .
The actual cause of breast cancer is unknown. Probably it is a multietiological as well as a multiform disease. Several risk factors have been found, including genetic, hormonal, nutritional, physical and morphological factors (Lynch et al., 1984; Thomas, 1984; Mettlin, 1984) . The development of breast cancer, the occurrence of metastases and the survival of patients vary from case to case. The role of chemical carcinogenesis in human breast cancer is unclear. However, in mice and rats, mammary tumours can be induced by treatment with polycyclic aromatic hydrocarbons, such as benzo(a)pyrene (BP) and 7,12-dimethylbenz(a)anthracene (Furr & Jordan, 1984) .
In Both oestrogen (ER) and progesterone receptors (PR) of breast cancer tissues were determined by the dextran charcoal method (Koreman & Dukes, 1970) . The oestrogen receptor concentrations were considered positive (ER +) when they contained 4 fmol mg-' protein or thatover, and negative (ER -) when they were under that level. Progesterone receptor concentrations were considered positive (PR +) when they contained at least 7 fmol mg-' protein and negative (PR -) when they contained less.
AHH assay AHH activity in tumour microsomes was measured by the fluorometric method (Nebert & Gelboin, 1968) . The reaction was carried out at 37C for 60 min in dark using 900 p1 of tumour microsomal suspension (0.2-4 mg protein ml-') in a final incubation volume of I ml. An aliquot of every sample suspension was boiled for 10min and assayed with samples for individual blank correction. AHH activity is expressed as fmol product (equivalent to 30H-BP) formed per mg protein per min. The activity was considered to be detectable when the difference of the active and the boiled sample fluorescence intensity was twice as high as the variation in the duplicate determination. This corresponds to 5 fmol mg-' protein min-'. The protein concentration was determined according to Peterson (1977) using bovine serum albumin as a standard.
Treatment andfollow-up ofpatients All cancer patients were treated with mastectomy and, by only a few exceptions, with evacuation of the same side axillary lymph nodes. After the operation, the patients were sent to an oncological unit, where radiation therapy was given to all patients whose tumour size was TINIMO or larger. Anti-oestrogens (tamoxifen) or cytotoxic drugs were administered individually according to steroid receptor and metastatic status (Table II) . According to the routine treatment schedule used in Finland, the patients thereafter visited the oncological out-patient clinic every 3-6 months. The relapses and deaths of patients were recorded, and the status of patients exactly 4 years after the operation was used in survival evaluation.
Statistics
Data processing was carried out on an Olivetti M280 computer, and the appropriate statistics were obtained using SYSTAT package (Wilkinson, 1986) , BMDP1L and BMDP2L programme (Dixon, 1985) . in which the AHH activity was less than 24 fmol min-mg-' (n = 51), the medium AHH group showed activities between 24 and 75 fmol min-' mg"' (n = 50), and the high AHH group showed activities above 75 fmol min-' mg-' (n = 52). A clear prognostic difference both in overall and in disease-free survival could be identified between the groups (Figure 2) 
Discussion
The low activities and the wide variation of AHH activities in human breast tumours found in the present work were similar to those reported by Mason and Okey (1981) . Large interindividual variations in AHH activities were also found in other human extrahepatic tissues, such as lung (Cohen et al., 1979; Sabadie et al., 1981; Roberts et al., 1986) , lymphocytes (Kellerman et al., 1973) and placenta (Gurtoo et al., 1983 Our main result, which is that high AHH activity in breast cancer tissue predicts a bad prognosis of the disease, is a new one. The AHH activity of benign tumours was significantly lower than that in carcinomas and cancers with good prognosis lower than that of bad prognosis (though there were many individual exceptions). This suggests unavoidably the possibility of AHH-mediated carcinogenic activation in the most aggressive tumours.
Both higher and lower AHH activities in tumours compared to normal tissue have been reported to occur in human and chemically induced animal cancers. Human uterine leiomyomas were reported to show higher cytochrome P450 activity than adjacent normal myometrium (Senler et al., 1985b) . In rat mammary tumours, higher AHH activities were found than in normal nonlactating mammary tissue (Mason & Okey, 1981) , whereas in most of the lung cancer patients, AHH activity was lower in the tumorous tissue than in the surrounding tissue (Sebadie et al., 1981) . The discrepancies of results probably indicate the difficulties to control or to identify all the possible factors, as well as the enormous heterogeneity of the various forms of cancers.
Animal experiments have shown that susceptibility to several types of polycyclic aromatic hydrocarbon-induced tumours is strongly associated with the Ah receptor-mediated inducibility of AHH (Pelkonen & Nebert, 1982) . AHH induction has also been confirmed in human tissues. It is induced in placenta by smoking (Pasanen et al., 1988b) and in cultured lymphocytes by treatment with chemicals such as bentz(a)antracene (Kouri et al., 1982; Kellerman et al., 1973) . Ah receptors were found in human tissues, and the induction mechanism was considered to be the same as in mice and rats. It has also been suggested that genetic differences in AHH inducibility in humans might be important in determining susceptibility to some cancer forms (Kouri et al., 1982) . But again, the results from different laboratories vary. Kouri et al. (1982) reported a positive correlation between high AHH inducibility in cultures of human lymphocytes and the occurrence of primary lung cancer, whereas Karki et al. (1987) found no difference between the lung patients and the controls. Also, no association was found between AHH inducibility and occurrences of leukaemias or solid tumours in children (Levine et al., 1984 (Mason & Okey, 1981 non-responsive to induction (Pasanen et al., 1988a) . The present knowledge about the association of chemical carcinogenesis to breast cancer mediated by AHH activity seems not to be enough to give an answer to why high AHH activity associates to a poor prognosis of breast cancer. A clarification of its causes and importance will need much further work. We do not know yet whether high AHH activity is the cause or a consequence of malignant transformation. Also, it may be an independent change, which, however, is concentrated in the most serious breast cancer cases.
The most important prognostic indicator for breast cancer have been found to be tumour size and the extent of axillary lymph node involvement (Carter et al., 1989) . Lymph node status seems to serve as an indicator of a tumour's ability to spread. Distant metastases are the cause of deaths in most patients. In the present work, logarithm of AHH activity in carcinomas correlated positively with the occurrence of axillary lymph nodes. Tumour size, the presence of nodal and distant metastases correlated with each other. The three most important prognostic factors for disease-free intervals in our primary breast cancer patients were found to be metastases, log AHH and tumour size. For the overall survival, the importance of nodal status and progesterone receptors were also as a prognostic factors revealed, but log AHH still included in the independent prognostic factors.
Some negative correlation after logarithm transformation was found between AHH activity and steroid receptors. The presence of oestrogen and progesterone receptors in breast tumour increases the likelihood that the patient will respond to endocrine therapy, but higher levels of oestrogen receptors are associated with a greater probability of disease-free survival (Carter et al., 1989) .
Because cytochrome P450 enzymes metabolise tamoxifen as well as other anti-estrogens (Robinson & Jordan, 1988) , a high AHH activity may correlate with enzymes which inactivate the chemotherapeutic agents within the tumour itself, and may alter significantly the response of the tumour to the drug (Senler et al., 1985a) . This could explain the poor prognosis of our high-AHH patients, who were treated with antiestrogens. Because our patient material was too heterogenous, the results did not give any clear confirmation to this interesting possibility. However, the increased metabolism of anti-oestrogens cannot explain all our results, and a better clarification of this problem will be the aim for our future studies.
